Topic: "Biosimilars, PBMs, and the Future of Formulary Design"

• How major PBMs are becoming manufacturers and preferring their own products.
• Case studies on how biosimilars reduce specialty drug costs.
• How to push PBMs for biosimilar adoption in formulary design.

Key Takeaways:

• Understand the role of PBMs as manufacturers and its impact on formularies.
• Strategies for promoting biosimilar adoption.
• Identifying and avoiding conflicts of interest in PBM-managed formularies.